Formulary Search Results for: SODIUM ZIRCONIUM CYCLOSILICATE emergency
16.2 Specific antidotes - View Category
5.1.7 Some other antibacterials - View Category
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
Prescribing Notes:
Risedronate is the second line bisphosphonate for osteoporosis and should only be used in patients who either fail to tolerate alendronic acid because of gastrointestinal side effects or when alendronic acid is considered inappropriate because of existing active dyspeptic symptoms. Treatment of osteoporosis in men at high risk of fractures remains non-Formulary.
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
9.8.1 Drugs used in metabolic disorders - View Category
Restrictions:
This is an orphan product and restricted to specialist initiation.
Prescribing Notes:
Available granule formulations are not dose equivalent and are not interchangeable and should be prescribed by brand name to avoid confusion.
16.2 Specific antidotes - View Category
8.4 Drugs for cytotoxic-induced side effects - View Category
Restrictions:
Restricted to specialist use only for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours.
4.8.1 Control of the epilepsies - View Category
Restrictions:
Restricted to specialist initiation only.
Prescribing Notes:
Children exposed to valproate in utero are at high risk of developmental disorder and congenital malformations. For further information and communication materials for prescribers to use in their discussions with patients, see MHRA guidance here.
Valproate should NOT be used routinely in women of child-bearing age for the treatment of Bipolar Disorder. If it is deemed clinically necessary, then all aspects of the prevent programme MUST be followed and documented.
7.3.5 Emergency contraception - View Category
Prescribing Notes:
- Ulipristal is licensed for use in women presenting up to 120 hours after unprotected intercourse for whom the insertion of an IUD is not acceptable.
- Please follow the CoSRH guidance for appropriate use.